MedTrace Logo

Randomized Trial of Telemedicine for Diabetes Care

NCT00271739 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1665

Last updated 2023-09-18

Study results available
· View outcomes & findings →

Summary

The IDEATel study is a multicenter randomized controlled trial to evaluate the efficacy, acceptability, and cost-effectiveness of telemedicine case management to provide diabetes care to elderly Medicare beneficiaries residing in medically underserved areas of New York State.

Conditions

Interventions

DEVICE

Telemedicine Unit (HTU)

This study involves the deployment of a home telemedicine unit (HTU). The HTU provides 3 critical functions for patients: videoconferencing, access to information resources and e-mail through a web-enabled workstation, and medical data acquisition through an electronic device interface. The HTUs also included a glucometer and a blood pressure cuff interfaced directly with the HTU.

OTHER

usual care

usual diabetes care, as provided by primary care providers

Sponsors & Collaborators

  • State University of New York - Upstate Medical University

    collaborator OTHER

  • Columbia University

    lead OTHER

Principal Investigators

  • Steven Shea, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-12-31
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00271739 on ClinicalTrials.gov